AKT1 and thyroid gland carcinoma: Several reports have shown that gene mutations in the PI3K/AKT pathway are mainly present in poorly differentiated thyroid cancer tissues [29–31], suggesting that the activation of the PI3K/AKT signaling pathway may play an important role in the development and progression of thyroid cancer.